We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > bacteriophage

News List

Phage Display-Based Gene Delivery: A Viable Platform Technology for COVID-19 Vaccine Design and Development firstwordpharma
July 08, 2021
Researchers at Rutgers Cancer Institute of New Jersey, Rutgers New have demonstrated that a technology with favorable biological attributes known as phage display could be a viable platform for the development of new vaccines to protect against COVID-19.
NIAID grants $2.5m to 12 institutes for bacteriophage therapy research pharmaceutical-business-review
March 12, 2021
A branch of the National Institutes of Health (NIH), the National Institute of Allergy and Infectious Diseases (NIAID) has granted $2.5m to 12 institutes across the world for bacteriophage therapy research.
Janssen signs a $818m CRISPR products deal with Locus Biosciences pharmaceutical-technology
January 07, 2019
Janssen Pharmaceuticals has signed an exclusive collaboration and licence agreement with biotechnology firm Locus Biosciences for CRISPR products intended to treat bacterial infections.....
Roivant and iNtRON sign licensing deal for SAL200 pharmaceutical
November 21, 2018
Roivant Sciences and iNtRON Biotechnology have signed a $667.5m global licensing agreement for SAL200, which is an investigational biologic to treat infectious diseases caused by antibiotic-resistant staphylococci.